Utreglutide (GL0034), a novel GLP-1RA, increases liver FGF-21 and demonstrates significant efficacy on weight loss, HbA1c, and triglycerides in db/db mice

被引：0
|
作者：
Thennati, R. [1 ]
Burade, V. [1 ]
Natarajan, M. [1 ]
Garcia-Ocana, A. [2 ]
Rutter, G. [3 ,4 ]
Pratley, R. E. [5 ]
Thorens, B. [6 ]
Vilsboll, T. [7 ,8 ]
机构：
[1] Sun Pharmaceut Ind Ltd, Vadodara, India
[2] Arthur Riggs Diabet & Metab Res Inst, Dept Mol & Cellular Endocrinol, Duarte, CA USA
[3] Imperial Coll London, Dept Metab, Digest, Reprod, London, England
[4] Univ Montreal, Crchum, Quebec City, PQ, Canada
[5] AdventHlth, Translat Res Inst Metab & Diabet, Orlando, FL USA
[6] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland
[7] Steno Diabet Ctr Copenhagen, Clin Res, Herlev, Denmark
[8] Univ Copenhagen, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
738
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 6 条
  • [1] GL0034 (Utreglutide), a Novel GLP-1RA, Increases Liver FGF-21 and Demonstrates Significant Efficacy on Weight Loss, HbA1c, and Triglycerides in db/db Mice
    Thennati, Rajamannar
    Burade, Vinod S.
    Natarajan, Muthukumaran
    Garcia-Ocana, Adolfo
    Rutter, Guy A.
    Pratley, Richard E.
    Thorens, Bernard
    Vilsboll, Tina
    DIABETES, 2024, 73
  • [2] A Novel Long-Acting GLP-1 Agonist (GL0034) Demonstrates Remarkable Efficacy on HbA1c, Weight Loss, and Triglycerides in a Model of Type 2 Diabetes, the db/db Mouse
    Thennati, Rajamannar
    Burade, Vinod S.
    Vilsboll, Tina
    Thorens, Bernard
    Rutter, Guy A.
    DIABETES, 2020, 69
  • [3] A novel long-acting GLP-1 agonist (GL0034) demonstrates remarkable efficacy on HbA1c, weight loss and triglycerides in a model of type 2 diabetes, the db/db mouse
    Anholm, C.
    Kumarathurai, P.
    Skytte, M. G. J.
    Nielsen, O. W.
    Kristiansen, O. P.
    Barker, P.
    Burling, K.
    Fenger, M.
    Madsbad, S.
    Sajadieh, A.
    Haugaard, S. B.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S279 - S280
  • [4] Efficacy of HbA1c Changes, Weight Changes, and Blood Pressure Changes in GLP-1RA Daily Treatment or GLP-1RA Weekly Treatment in Type 2 Diabetes
    Cai, Xiaoling
    Yang, Wenjia
    Zhang, Simin
    Ji, Linong
    DIABETES, 2019, 68
  • [5] A novel, long-acting dual agonist for GIPR/GLP-1R, HISHS-2001, demonstrates effects on HbA1c and weight loss in the db/db mouse model of type 2 diabetes
    Thennati, R.
    Burade, V.
    Garcia-Ocana, A.
    Pratley, R. E.
    Rutter, G. A.
    Vilsboll, T.
    Thorens, B.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 242 - 242
  • [6] GL0034, A novel long-acting glucagon-like peptide 1 receptor agonist exhibits significant efficacy in aged db/db mouse model of non-alcoholic fatty liver disease (NAFLD)
    Thennati, Rajamannar
    Burade, Vinod
    Garcia-Ocana, Adolfo
    Pratley, Richard E.
    Rutter, Guy
    Vilsboll, Tina
    Thorens, Bernard
    JOURNAL OF HEPATOLOGY, 2022, 77 : S710 - S710
1